Lung cancer trials in Switzerland

In Switzerland 65 Also abroad 2733

65 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
Where
Basel, Sankt Gallen
Age
18 years and over
People
131 worldwide
Run by
CatalYm GmbH
See details and how to joinNCT07246863 · EU 2024-516794-70-00
Phase 3Taking people
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Where
Lausanne, Sankt Gallen, Thun, Villars-sur-Glâne
Age
18 years and over
People
750 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07361510 · EU 2025-523586-18-00
No phaseTaking people
LUCINAE Registry: Thoracic Cancers During Pregnancy
Where
Baden, Bellinzona, Geneva, Winterthur
Age
18 years and over
People
100
Run by
Oncology Institute of Southern Switzerland
See details and how to joinNCT07699861
No phaseNot yet taking people in Switzerland
Impact of Lung Cancer Screening With Chest Scans Combined With Coaching on Smoking Cessation in Heavy Smokers
Where
Fribourg
Age
50 years to 79 years
People
116
Run by
Hôpital Fribourgeois
See details and how to joinNCT07860359
Phase 2Taking people
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
Where
Basel, Fribourg, Sankt Gallen
Age
18 years and over
People
107 worldwide
Run by
CatalYm GmbH
See details and how to joinNCT07098988 · EU 2024-516792-32-01
No phaseTaking people
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
Where
Bern, La Chaux-de-Fonds, Sankt Gallen, Zurich
Age
18 years and over
People
600 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04790253
No phaseTaking people
European Real-World Registry for Use of the Ion Endoluminal System
Where
Zurich
Age
18 years and over
People
1,200 worldwide
Run by
Intuitive Surgical
See details and how to joinNCT06923774
Phase 2/3Taking people
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Where
Baden, Bellinzona, Sankt Gallen
Age
18 years and over
People
500 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07100080
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Chur, Sankt Gallen, Winterthur
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
Phase 3Taking people
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Where
Lucerne
Age
18 years and over
People
450 worldwide
Run by
Nuvalent Inc.
See details and how to joinNCT06765109 · EU 2024-517553-26-00
Phase 3Taking people
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Where
Bern, Zurich
Age
18 years and over
People
714 worldwide
Run by
Pfizer
See details and how to joinNCT06758401 · EU 2024-517968-36-00
Phase 3Taking people
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Where
Lausanne
Age
18 years and over
People
830 worldwide
Run by
AstraZeneca
See details and how to joinNCT06868277 · EU 2024-517780-24-00
Phase 4Taking people
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy
Where
Basel
Age
18 years and over
People
550 worldwide
Run by
Intuitive Surgical
See details and how to joinNCT07761351
Phase 3Taking people
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Where
Basel Town, Geneva, Lausanne, Lugano
Age
18 years and over
People
531 worldwide
Run by
AbbVie
See details and how to joinNCT07365241 · EU 2025-523819-11-00
Phase 2Taking people
A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
Where
Baden, Fribourg, Geneva, Sankt Gallen
Age
18 years and over
People
48 worldwide
Run by
ETOP IBCSG Partners Foundation
See details and how to joinNCT07203053 · EU 2025-522288-13-00
Phase 3Taking people
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
Where
Zurich
Age
18 years to 99 years
People
400 worldwide
Run by
Amgen
See details and how to joinNCT07778316
No phaseTaking people
Lung cAncer Robotic Comparative Study
Where
Zurich
Age
18 years and over
People
600 worldwide
Run by
Intuitive Surgical
See details and how to joinNCT06038227
Phase 1Taking people
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
Where
Sankt Gallen
Age
18 years to 99 years
People
160 worldwide
Run by
Amgen
See details and how to joinNCT07531095 · EU 2025-522888-15-00
Phase 3Taking people
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Where
Bern, Sankt Gallen, Villars-sur-Glâne
Age
18 years and over
People
540 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00
Phase 1Taking people
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Where
Geneva, Lausanne
Age
18 years to 100 years
People
162 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06562192
No phaseTaking people
Effect of a Music Intervention in Reducing Distress and Pain in Patients With Lung Cancer Undergoing Mini-invasive Surgery
Where
Bellinzona
Age
18 years and over
People
74
Run by
Oncology Institute of Southern Switzerland
See details and how to joinNCT07235098
Phase 1Taking people
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Where
Chur, Lausanne
Age
18 years and over
People
1,006 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00
Phase 2Taking people
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Where
Lausanne
Age
18 years to 70 years
People
170 worldwide
Run by
Iovance Biotherapeutics, Inc.
See details and how to joinNCT04614103 · EU 2024-510778-26-00
Phase 1Taking people
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Where
Chur, Fribourg, Winterthur
Age
18 years and over
People
220 worldwide
Run by
Amgen
See details and how to joinNCT06598306 · EU 2024-511838-12-00
Phase 2Taking people
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
Where
Baden, Basel, Bern, Sankt Gallen, Sion, Solothurn, Winterthur
Age
18 years and over
People
44 worldwide
Run by
ETOP IBCSG Partners Foundation
See details and how to joinNCT05718323 · EU 2022-502092-33-00